Kestra Medical Technologies (NASDAQ:KMTS) Revenue Beat and EPS Miss Create Mixed Setup After Recent Rally
Kestra Medical Technologies beat Q4 revenue estimates at $28.64M but missed EPS forecasts with a -$0.67 loss. The stock surged 20% in the last month despite flat after-hours trading.
Read the full article2d agoen
You might also wanna read
Kestra Medical Technologies Ltd (KMTS) Q4 2026 Earnings Call Highlights: Record Revenue Growth .
Despite a significant net loss, Kestra Medical Technologies Ltd (KMTS) reports robust revenue growth and strategic advancements in sales ter
GuruFocus·2d ago
Is Kestra Medical Technologies Ltd (KMTS) Positioned for Growth After Q4 Earnings? EPS: -0. .
Full-Year Revenue Surpasses Analyst Estimates, Yet Losses Persist Related Stocks: KMTS
GuruFocus·2d ago
Q4 2026 Kestra Medical Technologies Ltd Earnings Call Transcript
Related Stocks: KMTS
GuruFocus·2d ago
Kestra Medical Technologies (KMTS) Reports Strong Q4 Fiscal 2026 Earnings
Related Stocks: KMTS
GuruFocus·2d ago
Kestra Medical (KMTS) Q4 2026 Earnings Call Transcript
Revenue surged 66% in Q4 as prescriptions climbed 63% year over year.
Bars·2d ago
KMTS SWOT Analysis: Key Insights from 10-K Filing
Analyzing Strengths, Weaknesses, Opportunities, and Threats for Kestra Medical Technologies Ltd Related Stocks: KMTS
GuruFocus·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.